$0.09 EPS Expected for Golden Ocean Group Limited (GOGL); Immunomedics Has 1.65 Sentiment

January 14, 2018 - By Marie Mckinney

Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody products for the targeted treatment of cancer, autoimmune disorders, and other diseases. The company has market cap of $2.65 billion. The firm engages in developing antibody-drug conjugate products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAN5-SN-38 ADC that is in Phase II trials for the treatment of solid tumors and metastatic colorectal cancer; and IMMU-140 that targets HLA-DR for the potential treatment of liquid cancers. It currently has negative earnings. It also develops products for the treatment of cancer and autoimmune diseases, including epratuzumab, anti-CD22 antibody; veltuzumab, anti-CD20 antibody; milatuzumab, anti-CD74 antibody; and IMMU-114, a humanized anti-HLA-DR antibody.

Analysts expect Golden Ocean Group Limited (NASDAQ:GOGL) to report $0.09 EPS on February, 14.They anticipate $0.03 EPS change or 50.00% from last quarter’s $0.06 EPS. GOGL’s profit would be $13.16 million giving it 24.83 P/E if the $0.09 EPS is correct. The stock increased 1.59% or $0.14 during the last trading session, reaching $8.94. About 173,560 shares traded. Golden Ocean Group Limited (NASDAQ:GOGL) has risen 93.33% since January 14, 2017 and is uptrending. It has outperformed by 76.63% the S&P500.

Acuta Capital Partners Llc holds 16.88% of its portfolio in Immunomedics, Inc. for 6.74 million shares. Venbio Select Advisor Llc owns 14.74 million shares or 15.98% of their US portfolio. Moreover, First Light Asset Management Llc has 5.81% invested in the company for 1.31 million shares. The New York-based Ghost Tree Capital Llc has invested 5.78% in the stock. Ecor1 Capital Llc, a California-based fund reported 2.86 million shares.

Analysts await Immunomedics, Inc. (NASDAQ:IMMU) to report earnings on February, 8. They expect $-0.10 EPS, up 37.50% or $0.06 from last year’s $-0.16 per share. After $-0.16 actual EPS reported by Immunomedics, Inc. for the previous quarter, Wall Street now forecasts -37.50% EPS growth.

Since January 1, 0001, it had 0 insider purchases, and 6 insider sales for $2.10 million activity.

The stock increased 1.60% or $0.26 during the last trading session, reaching $16.51. About 2.27 million shares traded. Immunomedics, Inc. (IMMU) has risen 76.26% since January 14, 2017 and is uptrending. It has outperformed by 59.56% the S&P500.

Among 7 analysts covering Golden Ocean Group (NASDAQ:GOGL), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Golden Ocean Group had 15 analyst reports since September 1, 2015 according to SRatingsIntel. JP Morgan initiated the shares of GOGL in report on Thursday, October 15 with “Neutral” rating. The firm has “Underweight” rating by Morgan Stanley given on Tuesday, December 15. The stock of Golden Ocean Group Limited (NASDAQ:GOGL) has “Overweight” rating given on Friday, April 7 by JP Morgan. DNB Markets upgraded the shares of GOGL in report on Monday, March 7 to “Buy” rating. As per Wednesday, March 15, the company rating was upgraded by Pareto. The stock of Golden Ocean Group Limited (NASDAQ:GOGL) earned “Underweight” rating by JP Morgan on Tuesday, January 26. Clarkson Capital downgraded the stock to “Neutral” rating in Tuesday, February 9 report. On Thursday, April 6 the stock rating was upgraded by DNB Markets to “Buy”. The stock has “Buy” rating by Zacks on Tuesday, September 1. As per Wednesday, March 1, the company rating was upgraded by JP Morgan.

Golden Ocean Group Limited, a shipping company, engages in the transportation of bulk commodities worldwide. The company has market cap of $1.31 billion. It owns and operates a fleet of dry bulk vessels, including Newcastlemax, Capesize, Kamsarmax, Panamax, and Supramax vessels. It currently has negative earnings. The firm transports bulk commodities, such as ores, coal, grains, and fertilizers along worldwide shipping routes.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>